相似文献
1
Helicobacter pylori virulence factors in gastric carcinogenesis.
Cancer Lett. 2009 Sep 8;282(1):1-8. doi: 10.1016/j.canlet.2008.11.016. Epub 2008 Dec 25.
2
Influence of Helicobacter pylori virulence factors CagA and VacA on pathogenesis of gastrointestinal disorders.
Microb Pathog. 2018 Apr;117:43-48. doi: 10.1016/j.micpath.2018.02.016. Epub 2018 Feb 9.
3
Virulence Factor Cytotoxin-Associated Gene A (CagA)-Mediated Gastric Pathogenicity.
Int J Mol Sci. 2020 Oct 8;21(19):7430. doi: 10.3390/ijms21197430.
4
The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in Germany.
Int J Cancer. 2000 Aug 1;87(3):322-7.
5
6
Clinical relevance of Helicobacter pylori vacA and cagA genotypes in gastric carcinoma.
Best Pract Res Clin Gastroenterol. 2014 Dec;28(6):1003-15. doi: 10.1016/j.bpg.2014.09.004. Epub 2014 Oct 2.
7
Role of Helicobacter pylori virulence factor cytotoxin-associated gene A in gastric mucosa-associated lymphoid tissue lymphoma.
World J Gastroenterol. 2013 Dec 7;19(45):8219-26. doi: 10.3748/wjg.v19.i45.8219.
8
CagA and Cag type IV secretion system activity have key roles in triggering gastric transcriptional and proteomic alterations.
Infect Immun. 2025 Apr 8;93(4):e0059524. doi: 10.1128/iai.00595-24. Epub 2025 Mar 6.
9
A unique strain to study gastric cancer development.
Microbiol Spectr. 2025 Jan 7;13(1):e0216324. doi: 10.1128/spectrum.02163-24. Epub 2024 Dec 6.
10
Helicobacter pylori promotes the expression of Krüppel-like factor 5, a mediator of carcinogenesis, in vitro and in vivo.
PLoS One. 2013;8(1):e54344. doi: 10.1371/journal.pone.0054344. Epub 2013 Jan 23.
引用本文的文献
1
Detection of virulence genes in Helicobacter pylori and its correlation with drug resistance by polymerase chain reaction.
Eur J Med Res. 2025 Jun 24;30(1):523. doi: 10.1186/s40001-025-02792-0.
2
Characterization of and virulence genes in dyspeptic patients at a teaching hospital in Ghana.
Pan Afr Med J. 2024 Apr 22;47:204. doi: 10.11604/pamj.2024.47.204.39135. eCollection 2024.
3
High-Salt Diet Exacerbates Infection and Increases Gastric Cancer Risks.
J Pers Med. 2023 Aug 28;13(9):1325. doi: 10.3390/jpm13091325.
4
Synergistic Antibacterial and Anti-Inflammatory Effects of Nisin and Lactic Acid in Yogurt against and Human Gastric Cells.
Food Sci Anim Resour. 2023 Sep;43(5):751-766. doi: 10.5851/kosfa.2023.e34. Epub 2023 Sep 1.
5
Characterization of TelE, a T7SS LXG Effector Exhibiting a Conserved C-Terminal Glycine Zipper Motif Required for Toxicity.
Microbiol Spectr. 2023 Aug 17;11(4):e0148123. doi: 10.1128/spectrum.01481-23. Epub 2023 Jul 11.
6
Pregnancy and Gastric Cancer: A Narrative Review.
Diagnostics (Basel). 2023 May 29;13(11):1909. doi: 10.3390/diagnostics13111909.
7
Downregulation of miR‑7 and miR‑153 is involved in CagA induced gastric carcinogenesis and progression.
Int J Oncol. 2023 Jul;63(1). doi: 10.3892/ijo.2023.5527. Epub 2023 May 26.
8
Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications.
Signal Transduct Target Ther. 2023 May 13;8(1):201. doi: 10.1038/s41392-023-01406-7.
9
Updated Epidemiology of Gastric Cancer in Asia: Decreased Incidence but Still a Big Challenge.
Cancers (Basel). 2023 May 6;15(9):2639. doi: 10.3390/cancers15092639.
10
Virulence Factors and Clarithromycin Resistance-Associated Mutations in Mexican Patients.
Pathogens. 2023 Feb 2;12(2):234. doi: 10.3390/pathogens12020234.
本文引用的文献
1
Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms.
Gastroenterology. 2008 Jul;135(1):91-9. doi: 10.1053/j.gastro.2008.03.041. Epub 2008 Mar 25.
2
vacA i-region subtyping.
Gastroenterology. 2008 Apr;134(4):1267; author reply 1268. doi: 10.1053/j.gastro.2007.11.062. Epub 2008 Feb 8.
3
Gastric Cancer Consensus conference recommends Helicobacter pylori screening and treatment in asymptomatic persons from high-risk populations to prevent gastric cancer.
Am J Gastroenterol. 2008 Mar;103(3):510-4. doi: 10.1111/j.1572-0241.2008.01819.x.
4
Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors.
Cancer Res. 2008 Jan 15;68(2):379-87. doi: 10.1158/0008-5472.CAN-07-0824.
5
Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse.
Proc Natl Acad Sci U S A. 2008 Jan 22;105(3):1003-8. doi: 10.1073/pnas.0711183105. Epub 2008 Jan 11.
6
Integrin subunit CD18 Is the T-lymphocyte receptor for the Helicobacter pylori vacuolating cytotoxin.
Cell Host Microbe. 2008 Jan 17;3(1):20-9. doi: 10.1016/j.chom.2007.11.003.
7
Host-bacterial interactions in Helicobacter pylori infection.
Gastroenterology. 2008 Jan;134(1):306-23. doi: 10.1053/j.gastro.2007.11.009.
8
Analysis of detergent-resistant membranes of Helicobacter pylori infected gastric adenocarcinoma cells reveals a role for MARK2/Par1b in CagA-mediated disruption of cellular polarity.
Cell Microbiol. 2008 Mar;10(3):781-94. doi: 10.1111/j.1462-5822.2007.01084.x. Epub 2007 Nov 13.
9
Helicobacter exploits integrin for type IV secretion and kinase activation.
Nature. 2007 Oct 18;449(7164):862-6. doi: 10.1038/nature06187.
10
Helicobacter pylori vacuolating cytotoxin inhibits activation-induced proliferation of human T and B lymphocyte subsets.
J Immunol. 2007 Oct 15;179(8):5433-40. doi: 10.4049/jimmunol.179.8.5433.
Zotero 插件